Just Released
|
||
How Does the Trump Drug Pricing Blueprint Affect Medicaid?
A new issue brief from
the Kaiser Family Foundation examines how the Trump Administration’s recent
proposal for lowering prescription drug prices could affect Medicaid drug
spending, including the Medicaid Drug Rebate Program. The cost of
prescription drugs continues to be a major policy issue for policymakers, and
the federal government and many states are pursuing actions to try to lower
drug costs.
Filling
the need for trusted information on national health issues, the
Kaiser Family Foundation is a nonprofit organization based in San Francisco,
California.
|
||
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Thursday, May 31, 2018
How Does the Trump Drug Pricing Blueprint Affect Medicaid?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment